Company news
Intercure Ltd. (TASE:INCR) news
Intercure Ltd. news releases on 6ix. Latest, Apr 30, 2026: InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
Press releases & updates
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
April 30, 2026
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
March 3, 2026
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million
February 19, 2026
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
February 19, 2026
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation
November 3, 2025
InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow
October 8, 2025
InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands
September 19, 2025
InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025
May 1, 2025